Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katy K Tsai

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Seminars in Cutaneous Medicine and Surgery|May 4, 2019
Systemic therapy for advanced cutaneous squamous cell carcinomaKelly Fitzgerald, Katy K Tsai
Journal of Hematology & Oncology|November 1, 2015
Nivolumab plus ipilimumab in the treatment of advanced melanomaKaty K Tsai, Adil I Daud
Melanoma Management|September 8, 2018
Are PD-1 antibodies safe for use in metastatic uveal melanoma?Katy K Tsai, Alain P Algazi
Drugs|March 25, 2015
The Role of Anti-PD-1/PD-L1 Agents in Melanoma: Progress to DateKaty K Tsai, Adil I Daud
American Journal of Clinical Dermatology|June 23, 2025
Tumor-Infiltrating Lymphocyte Therapy for the Treatment of Metastatic MelanomaKaty K Tsai, Krishna V Komanduri
Current Oncology Reports|May 23, 2024
For the Long Haul: Management of Long-Term Survivors after Melanoma Systemic TherapyJordyn Silverstein, Neha Goyal, Katy K Tsai
Human Vaccines & Immunotherapeutics|January 28, 2015
PD-1 and PD-L1 antibodies for melanomaKaty K Tsai, Inés Zarzoso, Adil I Daud
Clinical Pharmacology and Therapeutics|August 10, 2017
Tyrosine Kinase Inhibitors and Male Reproductive HealthJoris J Ramstein, Katy K Tsai, James F Smith
Cancer|March 27, 2018
Obstacles to improving outcomes in the treatment of uveal melanomaKaty K Tsai, Kathryn B Bollin, Sapna P Patel
Female Pelvic Medicine & Reconstructive Surgery|March 29, 2012
Association between obesity, sexual activity and sexual function in women with pelvic floor disordersKaty K Tsai, Felisha Marques, Deborah L Myers, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Seminars in Cutaneous Medicine and Surgery|May 4, 2019
Systemic therapy for advanced cutaneous squamous cell carcinomaKelly Fitzgerald, Katy K Tsai
Journal of Hematology & Oncology|November 1, 2015
Nivolumab plus ipilimumab in the treatment of advanced melanomaKaty K Tsai, Adil I Daud
Melanoma Management|September 8, 2018
Are PD-1 antibodies safe for use in metastatic uveal melanoma?Katy K Tsai, Alain P Algazi
Drugs|March 25, 2015
The Role of Anti-PD-1/PD-L1 Agents in Melanoma: Progress to DateKaty K Tsai, Adil I Daud
American Journal of Clinical Dermatology|June 23, 2025
Tumor-Infiltrating Lymphocyte Therapy for the Treatment of Metastatic MelanomaKaty K Tsai, Krishna V Komanduri
Current Oncology Reports|May 23, 2024
For the Long Haul: Management of Long-Term Survivors after Melanoma Systemic TherapyJordyn Silverstein, Neha Goyal, Katy K Tsai
Human Vaccines & Immunotherapeutics|January 28, 2015
PD-1 and PD-L1 antibodies for melanomaKaty K Tsai, Inés Zarzoso, Adil I Daud
Clinical Pharmacology and Therapeutics|August 10, 2017
Tyrosine Kinase Inhibitors and Male Reproductive HealthJoris J Ramstein, Katy K Tsai, James F Smith
Cancer|March 27, 2018
Obstacles to improving outcomes in the treatment of uveal melanomaKaty K Tsai, Kathryn B Bollin, Sapna P Patel
Female Pelvic Medicine & Reconstructive Surgery|March 29, 2012
Association between obesity, sexual activity and sexual function in women with pelvic floor disordersKaty K Tsai, Felisha Marques, Deborah L Myers, et al.
Pageof 5